UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011338
Receipt number R000013261
Scientific Title Staining by Brilliant Blue G in the intraocular surgery
Date of disclosure of the study information 2013/08/01
Last modified on 2013/07/31 08:48:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Staining by Brilliant Blue G in the intraocular surgery

Acronym

Staining by Brilliant Blue G in the intraocular surgery

Scientific Title

Staining by Brilliant Blue G in the intraocular surgery

Scientific Title:Acronym

Staining by Brilliant Blue G in the intraocular surgery

Region

Japan


Condition

Condition

Ophthalmic diseases targeted for intraocular surgery

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Performing staining of the intraocular tissue by Brilliant Blue G to carry out the surgery safely during intraocular surgery and evaluate visual acuity,field of view,retinal thickness after surgery

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluate the visual acuity, retinal thickness, field of view after surgery, evaluate the safety of the surgery method using this drug as compared to the conventional method.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Use of Brilliant Blue G of the intraocular tissue staining during intraoperative surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) During intraocular surgery cases staining is necessary to anterior capsule of the lens and internal limiting membrane of the retina.
2) Patients were able gain agreement with from the person.

Key exclusion criteria

1) Patients who may have been pregnant or pregnant women, patients who wish pregnancy and patient breastfeeding
2) External eye disease activity
3) Patients physician deems inappropriate

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhisa Sugiyama

Organization

Kanazawa University

Division name

Department of Ophthalmology

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Michiharu Shimizu

Organization

Kanazawa University

Division name

Department of Ophthalmology

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa

TEL


Homepage URL


Email



Sponsor or person

Institute

Department of Ophthalmology, Kanazawa University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 04 Month 12 Day

Date of IRB


Anticipated trial start date

2013 Year 06 Month 01 Day

Last follow-up date

2013 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 08 Month 01 Day

Last modified on

2013 Year 07 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013261


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name